{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:12:52Z","timestamp":1762323172769},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T00:00:00Z","timestamp":1204502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T00:00:00Z","timestamp":1204502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2008,7,3]]},"DOI":"10.1038\/onc.2008.40","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T13:56:09Z","timestamp":1204552569000},"page":"4096-4106","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells"],"prefix":"10.1038","volume":"27","author":[{"given":"S","family":"Horn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Bergholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"J\u00fccker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"McCubrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Tr\u00fcmper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Stocking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"B\u00e4secke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,3]]},"reference":[{"key":"BFonc200840_CR1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4161\/cbt.3.8.994","volume":"3","author":"KE Bachman","year":"2004","unstructured":"Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S et al. (2004). The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3: 772\u2013775.","journal-title":"Cancer Biol Ther"},{"key":"BFonc200840_CR2","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1073\/pnas.0510857103","volume":"103","author":"AG Bader","year":"2006","unstructured":"Bader AG, Kang S, Vogt PK . (2006). Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci USA 103: 1475\u20131479.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc200840_CR3","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1038\/sj.onc.1209670","volume":"25","author":"C Billottet","year":"2006","unstructured":"Billottet C, Grandage VL, Gale RE, Quattropani A, Rommel C, Vanhaesebroeck B et al. (2006). A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. Oncogene 25: 6648\u20136659.","journal-title":"Oncogene"},{"key":"BFonc200840_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1096\/fasebj.14.7.895","volume":"14","author":"LR Borlado","year":"2000","unstructured":"Borlado LR, Redondo C, Alvarez B, Jimenez C, Criado LM, Flores J et al. (2000). Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J 14: 895\u2013903.","journal-title":"FASEB J"},{"key":"BFonc200840_CR5","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/sj.emboj.7600279","volume":"23","author":"C Bouchard","year":"2004","unstructured":"Bouchard C, Marquardt J, Bras A, Medema RH, Eilers M . (2004). Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J 23: 2830\u20132840.","journal-title":"EMBO J"},{"key":"BFonc200840_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2141.2005.05784.x","volume":"131","author":"M Bousquet","year":"2005","unstructured":"Bousquet M, Recher C, Queleen C, Demur C, Payrastre B, Brousset P . (2005). Assessment of somatic mutations in phosphatidylinositol 3-kinase gene in human lymphoma and acute leukaemia. Br J Haematol 131: 411\u2013413.","journal-title":"Br J Haematol"},{"key":"BFonc200840_CR7","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1158\/0008-5472.CAN-04-1170","volume":"64","author":"DK Broderick","year":"2004","unstructured":"Broderick DK, Di C, Parrett TJ, Samuels YR, Cummins JM, McLendon RE et al. (2004). Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64: 5048\u20135050.","journal-title":"Cancer Res"},{"key":"BFonc200840_CR8","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1182\/blood-2005-02-0583","volume":"106","author":"J Cammenga","year":"2005","unstructured":"Cammenga J, Horn S, Bergholz U, Sommer G, Besmer P, Fiedler W et al. (2005). Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate. Blood 106: 3958\u20133961.","journal-title":"Blood"},{"key":"BFonc200840_CR9","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","volume":"64","author":"IG Campbell","year":"2004","unstructured":"Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS et al. (2004). Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64: 7678\u20137681.","journal-title":"Cancer Res"},{"issue":"Part 2","key":"BFonc200840_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/bj3420287","volume":"342","author":"A Casamayor","year":"1999","unstructured":"Casamayor A, Morrice NA, Alessi DR . (1999). Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J 342 (Part 2): 287\u2013292.","journal-title":"Biochem J"},{"key":"BFonc200840_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/path.1725","volume":"205","author":"A Dutton","year":"2005","unstructured":"Dutton A, Reynolds GM, Dawson CW, Young LS, Murray PG . (2005). Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. J Pathol 205: 498\u2013506.","journal-title":"J Pathol"},{"key":"BFonc200840_CR12","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.1200\/JCO.2005.05.010","volume":"23","author":"S Frohling","year":"2005","unstructured":"Frohling S, Scholl C, Gilliland DG, Levine RL . (2005). Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 23: 6285\u20136295.","journal-title":"J Clin Oncol"},{"key":"BFonc200840_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/00062752-200207000-00003","volume":"9","author":"DG Gilliland","year":"2002","unstructured":"Gilliland DG, Griffin JD . (2002). Role of FLT3 in leukemia. Curr Opin Hematol 9: 274\u2013281.","journal-title":"Curr Opin Hematol"},{"key":"BFonc200840_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/sj.leu.2403653","volume":"19","author":"VL Grandage","year":"2005","unstructured":"Grandage VL, Gale RE, Linch DC, Khwaja A . (2005). PI3-kinase\/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia 19: 586\u2013594.","journal-title":"Leukemia"},{"key":"BFonc200840_CR15","doi-asserted-by":"publisher","first-page":"51606","DOI":"10.1074\/jbc.M310722200","volume":"278","author":"MA Gregory","year":"2003","unstructured":"Gregory MA, Qi Y, Hann SR . (2003). Phosphorylation by glycogen synthase kinase-3 controls c-Myc proteolysis and subnuclear localization. J Biol Chem 278: 51606\u201351612.","journal-title":"J Biol Chem"},{"key":"BFonc200840_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1182\/blood-2002-01-0177","volume":"101","author":"K Hashimoto","year":"2003","unstructured":"Hashimoto K, Matsumura I, Tsujimura T, Kim DK, Ogihara H, Ikeda H et al. (2003). Necessity of tyrosine 719 and phosphatidylinositol 3\u2032-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-Kit receptor tyrosine kinase with the Asp814Val mutation. Blood 101: 1094\u20131102.","journal-title":"Blood"},{"key":"BFonc200840_CR17","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/sj.onc.1205400","volume":"21","author":"B Hoffman","year":"2002","unstructured":"Hoffman B, Amanullah A, Shafarenko M, Liebermann DA . (2002). The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21: 3414\u20133421.","journal-title":"Oncogene"},{"key":"BFonc200840_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2605.x","volume":"77","author":"P Hummerdal","year":"2006","unstructured":"Hummerdal P, Andersson P, Willander K, Linderholm M, Soderkvist P, Jonsson JI . (2006). Absence of hot spot mutations of the PIK3CA gene in acute myeloid leukaemia. Eur J Haematol 77: 86\u201387.","journal-title":"Eur J Haematol"},{"key":"BFonc200840_CR19","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1158\/0008-5472.CAN-04-4114","volume":"65","author":"T Ikenoue","year":"2005","unstructured":"Ikenoue T, Kanai F, Hikiba Y, Obata T, Tanaka Y, Imamura J et al. (2005). Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65: 4562\u20134567.","journal-title":"Cancer Res"},{"key":"BFonc200840_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/emboj\/17.3.743","volume":"17","author":"C Jimenez","year":"1998","unstructured":"Jimenez C, Jones DR, Rodriguez-Viciana P, Gonzalez-Garcia A, Leonardo E, Wennstr\u00f6m S et al. (1998). Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 17: 743\u2013753.","journal-title":"EMBO J"},{"key":"BFonc200840_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/sj.leu.2402484","volume":"16","author":"M Jucker","year":"2002","unstructured":"Jucker M, Sudel K, Horn S, Sickel M, Wegner W, Fiedler W et al. (2002). Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO). Leukemia 16: 894\u2013901.","journal-title":"Leukemia"},{"key":"BFonc200840_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1073\/pnas.0408864102","volume":"102","author":"S Kang","year":"2005","unstructured":"Kang S, Bader AG, Vogt PK . (2005). Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102: 802\u2013807.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc200840_CR23","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1128\/MCB.16.8.4117","volume":"16","author":"A Klippel","year":"1996","unstructured":"Klippel A, Reinhard C, Kavanaugh WM, Apell G, Escobedo MA, Williams LT . (1996). Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol Cell Biol 16: 4117\u20134127.","journal-title":"Mol Cell Biol"},{"key":"BFonc200840_CR24","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1182\/blood-2006-02-003475","volume":"108","author":"SM Kornblau","year":"2006","unstructured":"Kornblau SM, Womble M, Qiu YH, Jackson CE, Chen W, Konopleva M et al. (2006). Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. Blood 108: 2358\u20132365.","journal-title":"Blood"},{"key":"BFonc200840_CR25","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/sj.onc.1208304","volume":"24","author":"JW Lee","year":"2005","unstructured":"Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW et al. (2005). PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24: 1477\u20131480.","journal-title":"Oncogene"},{"key":"BFonc200840_CR26","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1158\/1078-0432.CCR-04-2142","volume":"11","author":"DA Levine","year":"2005","unstructured":"Levine DA, Bogomolniy F, Yee CJ, Lash A, Barakat RR, Borgen PI et al. (2005). Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res 11: 2875\u20132878.","journal-title":"Clin Cancer Res"},{"key":"BFonc200840_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2407-5-29","volume":"5","author":"VS Li","year":"2005","unstructured":"Li VS, Wong CW, Chan TL, Chan AS, Zhao W, Chu KM et al. (2005). Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 5: 29.","journal-title":"BMC Cancer"},{"key":"BFonc200840_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.leu.2402725","volume":"17","author":"JM Luo","year":"2003","unstructured":"Luo JM, Yoshida H, Komura S, Ohishi N, Pan L, Shigeno K et al. (2003). Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Leukemia 17: 1\u20138.","journal-title":"Leukemia"},{"key":"BFonc200840_CR29","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/sj.leu.2404317","volume":"20","author":"S Malempati","year":"2006","unstructured":"Malempati S, Tibbitts D, Cunningham M, Akkari Y, Olson S, Fan G et al. (2006). Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias. Leukemia 20: 1572\u20131581.","journal-title":"Leukemia"},{"key":"BFonc200840_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/sj.leu.2404245","volume":"20","author":"AM Martelli","year":"2006","unstructured":"Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C et al. (2006). Phosphoinositide 3-kinase\/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 20: 911\u2013928.","journal-title":"Leukemia"},{"key":"BFonc200840_CR31","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1158\/0008-5472.CAN-04-0174","volume":"64","author":"YH Min","year":"2004","unstructured":"Min YH, Cheong JW, Kim JY, Eom JI, Lee ST, Hahn JS et al. (2004). Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia. Cancer Res 64: 5225\u20135231.","journal-title":"Cancer Res"},{"key":"BFonc200840_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.leu.2402874","volume":"17","author":"YH Min","year":"2003","unstructured":"Min YH, Eom JI, Cheong JW, Maeng HO, Kim JY, Jeung HK et al. (2003). Constitutive phosphorylation of Akt\/PKB protein in acute myeloid leukemia: its significance as a prognostic variable. Leukemia 17: 995\u2013997.","journal-title":"Leukemia"},{"key":"BFonc200840_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.leukres.2006.04.011","volume":"31","author":"CI Muller","year":"2007","unstructured":"Muller CI, Miller CW, Hofmann WK, Gross ME, Walsh CS, Kawamata N et al. (2007). Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene. Leuk Res 31: 27\u201332.","journal-title":"Leuk Res"},{"key":"BFonc200840_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.leu.2404057","volume":"20","author":"M Nyakern","year":"2006","unstructured":"Nyakern M, Tazzari PL, Finelli C, Bosi C, Follo MY, Grafone T et al. (2006). Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients. Leukemia 20: 230\u2013238.","journal-title":"Leukemia"},{"key":"BFonc200840_CR35","first-page":"7426","volume":"61","author":"AJ Philp","year":"2001","unstructured":"Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH et al. (2001). The phosphatidylinositol 3\u2032-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61: 7426\u20137429.","journal-title":"Cancer Res"},{"key":"BFonc200840_CR36","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood-2004-06-2494","volume":"105","author":"C Recher","year":"2005","unstructured":"Recher C, Beyne-Rauzy O, Demur C, Chicanne G, Dos Santos C, Mas VM et al. (2005). Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 105: 2527\u20132534.","journal-title":"Blood"},{"key":"BFonc200840_CR37","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1002\/j.1460-2075.1996.tb00602.x","volume":"15","author":"P Rodriguez-Viciana","year":"1996","unstructured":"Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD, Downward J . (1996). Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J 15: 2442\u20132451.","journal-title":"EMBO J"},{"key":"BFonc200840_CR38","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","volume":"108","author":"M Rudelius","year":"2006","unstructured":"Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES et al. (2006). Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 108: 1668\u20131676.","journal-title":"Blood"},{"key":"BFonc200840_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccr.2005.05.014","volume":"7","author":"Y Samuels","year":"2005","unstructured":"Samuels Y, Diaz Jr LA, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I et al. (2005). Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7: 561\u2013573.","journal-title":"Cancer Cell"},{"key":"BFonc200840_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.","journal-title":"Science"},{"key":"BFonc200840_CR41","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1182\/blood-2005-08-3076","volume":"107","author":"AE Schade","year":"2006","unstructured":"Schade AE, Powers JJ, Wlodarski MW, Maciejewski JP . (2006). Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 107: 4834\u20134840.","journal-title":"Blood"},{"key":"BFonc200840_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrc2109","volume":"7","author":"S Schubbert","year":"2007","unstructured":"Schubbert S, Shannon K, Bollag G . (2007). Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7: 295\u2013308.","journal-title":"Nat Rev Cancer"},{"key":"BFonc200840_CR43","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1084\/jem.20020824","volume":"196","author":"M Schwieger","year":"2002","unstructured":"Schwieger M, Lohler J, Friel J, Scheller M, Horak I, Stocking C et al. (2002). AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med 196: 1227\u20131240.","journal-title":"J Exp Med"},{"key":"BFonc200840_CR44","first-page":"503","volume":"3","author":"JG Shelton","year":"2004","unstructured":"Shelton JG, Blalock WL, White ER, Steelman LS, McCubrey JA . (2004). Ability of the activated PI3K\/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells. Cell Cycle 3: 503\u2013512.","journal-title":"Cell Cycle"},{"key":"BFonc200840_CR45","first-page":"4412","volume":"63","author":"R Shivakrupa","year":"2003","unstructured":"Shivakrupa R, Bernstein A, Watring N, Linnekin D . (2003). Phosphatidyl 3\u2032-kinase is required for growth of mast cells expressing the Kit catalytic domain mutant. Cancer Res 63: 4412\u20134419.","journal-title":"Cancer Res"},{"key":"BFonc200840_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/08977199309011023","volume":"8","author":"C Stocking","year":"1993","unstructured":"Stocking C, Bergholz U, Friel J, Klingler K, Wagener T, Starke C et al. (1993). Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line. Growth Factors 8: 197\u2013209.","journal-title":"Growth Factors"},{"key":"BFonc200840_CR47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1182\/blood-2004-08-3225","volume":"106","author":"P Sujobert","year":"2005","unstructured":"Sujobert P, Bardet V, Cornillet-Lefebvre P, Hayflick JS, Prie N, Verdier F et al. (2005). Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Blood 106: 1063\u20131066.","journal-title":"Blood"},{"key":"BFonc200840_CR48","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","volume":"108","author":"S Uddin","year":"2006","unstructured":"Uddin S, Hussain AR, Siraj AK, Manogaran PS, Al-Jomah NA, Moorji A et al. (2006). Role of phosphatidylinositol 3\u2032-kinase\/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108: 4178\u20134186.","journal-title":"Blood"},{"key":"BFonc200840_CR49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL . (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489\u2013501.","journal-title":"Nat Rev Cancer"},{"key":"BFonc200840_CR50","doi-asserted-by":"publisher","first-page":"42913","DOI":"10.1074\/jbc.M304172200","volume":"278","author":"MJ Wick","year":"2003","unstructured":"Wick MJ, Ramos FJ, Chen H, Quon MJ, Dong LQ, Liu F . (2003). Mouse 3-phosphoinositide-dependent protein kinase-1 undergoes dimerization and trans-phosphorylation in the activation loop. J Biol Chem 278: 42913\u201342919.","journal-title":"J Biol Chem"},{"key":"BFonc200840_CR51","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","volume":"102","author":"Q Xu","year":"2003","unstructured":"Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M . (2003). Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 102: 972\u2013980.","journal-title":"Blood"},{"key":"BFonc200840_CR52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature04747","volume":"441","author":"J Zhang","year":"2006","unstructured":"Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT et al. (2006). PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441: 518\u2013522.","journal-title":"Nature"},{"key":"BFonc200840_CR53","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/sj.leu.2403220","volume":"18","author":"S Zhao","year":"2004","unstructured":"Zhao S, Konopleva M, Cabreira-Hansen M, Xie Z, Hu W, Milella M et al. (2004). Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia 18: 267\u2013275.","journal-title":"Leukemia"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc200840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc200840","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc200840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T15:09:10Z","timestamp":1647875350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc200840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,3]]},"references-count":53,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2008,7,3]]}},"alternative-id":["BFonc200840"],"URL":"https:\/\/doi.org\/10.1038\/onc.2008.40","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,3]]},"assertion":[{"value":"9 November 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}